Next Article in Journal
Surveys of Knowledge and Awareness of Plastic Pollution and Risk Reduction Behavior in the General Population: A Systematic Review
Next Article in Special Issue
Multilevel Factors Influencing Perceived Barriers to Adjuvant Endocrine Therapy Among Breast Cancer Patients at Medication Onset
Previous Article in Journal
A Real-World Study on the Quality of Life of Consumers with Dentine Hypersensitivity and the Benefits of Hypersensitivity Toothpaste Use
 
 
Article
Peer-Review Record

An Investigation of Travel Distance and Timeliness of Breast Cancer Treatment Among a Diverse Cohort in the United States

Int. J. Environ. Res. Public Health 2025, 22(2), 176; https://doi.org/10.3390/ijerph22020176
by Swann Arp Adams 1,2,*, Oluwole Adeyemi Babatunde 3, Whitney E. Zahnd 4, Peiyin Hung 5,6, Karen E. Wickersham 1, Nathaniel Bell 7 and Jan M. Eberth 8
Reviewer 1:
Reviewer 2: Anonymous
Int. J. Environ. Res. Public Health 2025, 22(2), 176; https://doi.org/10.3390/ijerph22020176
Submission received: 20 December 2024 / Revised: 16 January 2025 / Accepted: 22 January 2025 / Published: 27 January 2025

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

I greatly respect the SC Center and the Senior Researchers. Unfortunately, I think the article can be greatly improved by adding a Geospatial Expert.  There are many nuances to seeking cancer treatment, including the kind of treatment characteristics that may have been surgery + radiation, Surgery + chemotherapy, Surgery + hormonal therapy, or just surgery alone, because the margins were "clean".  What about "White + Non-Hispanic" vs. "White + Hispanic"? 

On Page 2, line 52, the authors use the term, "suboptimal treatment".  How is this determined, and based on what?  Working for a NCI Cancer treatment center, this could be a pretty high standard, or not.  Cite your treatment standards. 

Working for a NCI Cancer Treatment Center, I am also aware that patients will come, and stay for long periods of time for treatment.

Treatment distances is a major issue.  Many NCI Cancer Centers also have "branch campuses" and mobile treatment infusion options.  Be sure and check that out.

Author Response

Please see attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

 

Dear Authors,

thank you for the possibility to read the paper.

I have read the paper, and I will try in the following to provide some comments to improve your research.

Good luck for the publication!

Comments for author File: Comments.pdf

Author Response

Please see attachment.  

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

The limitations of this study are clearly identified and are based on the fact that this is a single state study. However, this is apparent to the reader and those reviewing it for replication for future studies.  Perhaps the quality of the National Cancer Registry SEER data will improve to allow combined multiple state analyses in the future.

Reviewer 2 Report

Comments and Suggestions for Authors

Dear Authors,

I appreciate a lot the work that you have done to address all the comments.

I think that the integrations allow to have a more complete understanding of your research.

Back to TopTop